ICOSAVAX, INC.

Profile

Company Names

ICOSAVAX, INC.

Addresses

1616 EASTLAKE AVE. E, STE. 208, SEATTLE, WA 98102

2815 EASTLAKE AVE E, SUITE 300, SEATTLE, WA 98102

Phone Numbers

(858) 775-4523
(206) 336-5600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$129,737,077.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-03-19 
$99,729,701.00 
$99,729,701.00 
$0.00 
Equity 
1
2019-08-15 
$30,007,376.00 
$51,007,373.00 
$20,999,997.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CASSIA 
 
CEARLEY 
EXECUTIVE OFFICER
ICOSAVAX, INC.
TERRY 
 
GOULD 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  PROTEUS BIOMEDICAL INC   |  LIGHT SCIENCES ONCOLOGY INC   |  INCLINE THERAPEUTICS, INC.   |  NAUREX INC.   |  ONCOMED PHARMACEUTICALS INC   |  OUTPOST MEDICINE, LLC   |  ATOX BIO INC.   |  QPEX BIOPHARMA, INC.   |  ICOSAVAX, INC.
JASON 
 
HAFLER 
DIRECTOR
NEUROVIA, INC.   |  EXPANSION THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  ESCIENT PHARMACEUTICALS INC   |  ABCURO, INC.   |  MATCHPOINT THERAPEUTICS INC.   |  CHARACTER BIOSCIENCES, INC.   |  STAR THERAPEUTICS LLC
DOUGLAS 
A. 
HOLTZMAN 
EXECUTIVE OFFICER
ICOSAVAX, INC.
NIRANJAN 
 
KANESA-THASAN 
EXECUTIVE OFFICER
ICOSAVAX, INC.
PETER 
 
KOLCHINSKY 
DIRECTOR
RA CAPITAL HEALTHCARE FUND II, L.P.   |  RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD   |  RA CAPITAL HEALTHCARE FUND LP   |  CELLSCAPE CORP   |  DICERNA PHARMACEUTICALS INC   |  WAVE LIFE SCIENCES PTE LTD   |  CALIMMUNE, INC.   |  LANTOS TECHNOLOGIES, INC.   |  G1 THERAPEUTICS, INC.   |  SOJOURNIX, INC.   |  ADEO HEALTH SCIENCE, INC.   |  RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.   |  RA CAPITAL NEXUS FUND, L.P.   |  VAXESS TECHNOLOGIES, INC.   |  ICOSAVAX, INC.   |  ARS PHARMACEUTICALS, INC.   |  FREENOME HOLDINGS, INC.   |  RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.   |  RA CAPITAL NEXUS FUND III, L.P.   |  NATURE-S TOOLBOX, INC.   |  RA CAPITAL PLANETARY HEALTH FUND, L.P.   |  RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.   |  TERRESTRIAL BIO, INC.
MARK 
 
MCDADE 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  DERMIRA, INC.   |  PLATELET BIOGENESIS, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  TALARIS THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.   |  BOULDER CARE, INC.   |  SODA HEALTH, INC.   |  DUALITAS THERAPEUTICS, INC.
ERIC 
 
MOESSINGER 
DIRECTOR
EMULATE, INC.   |  PULSE THERAPEUTICS, INC.   |  MUSE BIOTECHNOLOGY, INC.   |  SQZ BIOTECHNOLOGIES CO   |  SEROTINY, INC.   |  EUPHRATES VASCULAR, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  VISBY MEDICAL, INC.   |  PARTILLION BIOSCIENCE CORP   |  DRAGON VASCULAR, INC.
CHARLES 
 
RICHARDSON 
EXECUTIVE OFFICER
ICOSAVAX, INC.
ADAM 
K. 
SIMPSON 
EXECUTIVE OFFICER, DIRECTOR
MERITAGE PHARMA INC   |  ICOSAVAX, INC.
TADATAKA 
 
YAMADA, M.D. 
DIRECTOR
PRECISION IBD, INC.   |  ICOSAVAX, INC.   |  PROMETHEUS BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-19 
2019-10-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#